GSK’s 2015 Annual Report and Responsible Business Supplement

GSK is a science-led global healthcare company that researches and develops innovative pharmaceuticals, vaccines, and consumer healthcare products.  Operating responsibly is fundamental to our strategic priorities. In our Annual Report and Responsible Business Supplement, we report our progress against 23 forward-looking commitments across four focus areas: 

  • Health for All: Find out how we are developing innovative products and improving access to healthcare for patients around the world.
     
  • Our Behavior: Read about how we are embedding our values throughout the business, including into the ways we research, develop, sell and market our products.
     
  • Our People: Learn how we create an inspiring and supportive work environment that encourages our employees to develop their capabilities and achieve their best.
     
  • Our Planet: Find out how we are managing the environmental impacts of our operations and products across their life cycle to reduce carbon emissions, water use and waste.

Learn more about GSK's responsibility

Join the conversation

Videos from Client

Content from this campaign

Inclusion & Opportunity
Our People in Focus: “Inspiring the Next Generation of Scientists”
By 2020, the UK alone will need 1 million new scientists and engineers to solve future challenges, including some of the biggest health challenges of tomorrow. As a research-led healthcare company, GSK is playing a leading role in inspiring young people to get into science, technology, engineering and maths (STEM) as well as providing a range of career opportunities.
Responsible Production & the Circular Economy
Our Behavior In Focus: “The Ethics and Compliance Academy”
Our values dictate how we behave and guide the decisions we make. Our Global Ethics and Compliance team play a major role in embedding a values-based culture by providing tools to establish robust internal controls and create an ethical culture where people feel comfortable raising concerns
Research & Reports
Health for All in Focus: “Humanitarian Emergency Response”
Every year millions of people are displaced by disasters and emergency situations. These crises can devastate families, leaving them without access to adequate food, shelter or healthcare.

GSK works with partners and humanitarian organisations to prepare for and respond to emergency situations. In some instances, we fast-track the development of life-saving vaccines, and in others, we contribute by donating cash, products and our employees’ time. We also invest in long-term rebuilding and reconstruction in the aftermath of a disaster.
Awards & Rankings
Health for All in Focus: “Responding to Ebola and Zika"
2014 saw a critical public health emergency with the outbreak of Ebola in West Africa, which demanded an urgent response and the impact continued in 2015. As well as providing humanitarian support to affected regions, GSK accelerated the development of our candidate vaccine for Ebola at an unprecedented rate, with trials now underway.
Awards & Rankings
Highlights from GSK’s 2015 Responsible Business Supplement
Operating responsibly is fundamental to GSK’s strategic priorities. Our success depends on our ability to research and develop innovative products and make them accessible for more people in a responsible way. In our Responsible Business Supplement, we report our progress against 23 forward-looking commitments across four areas: Health for all, Our behaviour, Our people and Our planet.